SG Americas Securities »

Crispr Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 26k 46.98
2024-06-30 $1.4M 26k 54.01
2024-03-31 $2.6M 39k 68.16
2023-12-31 $3.0M 48k 62.61
2023-09-30 $1.1M 23k 45.37
2023-06-30 $1.5M 27k 56.15
2023-03-31 $1.2M 27k 45.24
2022-12-31 $1.1M 27k 40.65
2022-09-30 $839k 13k 65.34
2022-06-30 $3.8M 63k 60.76
2022-03-31 $279k 4.4k 62.74
2021-12-31 $1.8M 23k 75.77
2021-09-30 $8.1M 72k 111.93
2021-06-30 $9.8M 61k 161.89
2021-03-31 $7.3M 60k 121.86
2020-12-31 $821k 5.4k 153.06
2020-09-30 $578k 6.9k 83.68
2020-06-30 $615k 8.4k 73.47
2019-12-31 $401k 6.6k 60.90
2019-09-30 $758k 19k 40.96